{"id":1180,"date":"2020-03-16T11:10:15","date_gmt":"2020-03-16T10:10:15","guid":{"rendered":"https:\/\/lensounds.com\/2020\/03\/16\/nomination-sylvain-fanie\/"},"modified":"2026-03-06T18:31:18","modified_gmt":"2026-03-06T17:31:18","slug":"atonco-announces-appointment-sylvain-fanier-new-chairman","status":"publish","type":"post","link":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/","title":{"rendered":"ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO"},"content":{"rendered":"\n

Atonco today announces that Sylvain Fanier, MSc. EMBA, will succeed Professor Jean-Fran\u00e7ois Chatal as Chairman effective March 16, 2020.<\/p>\n\n\n\n

Sylvain Fanier has dedicated his career to overseeing and driving the development of several global medical innovations in the healthcare sector. He brings to the company strategic leadership and a global perspective on business and financing, acquired over 30 years at major corporations such as Johnson & Johnson and CR Bard, as well as in medical startups. Specializing in disruptive medical innovation, he has supported the success of innovative companies such as Lemerpax, Cardioinsight, Sonoscanner, Soundbite Medical Solutions, Surgivisio, and Med-Innov through his consulting firm, Novariver.<\/p>\n\n\n\n

He holds a bachelor’s degree in biochemistry and a master’s degree in biology with a specialization in physiology from the Universit\u00e9 Paul Sabatier in Toulouse. He also holds an EMBA from ESSEC, Paris, France.<\/p>\n\n\n\n

Sylvain serves on the board of directors of Soundbite Medical Solutions Inc. (Montreal, Canada) and Ecential Robotics SAS (Grenoble, France).<\/p>\n\n\n\n

I am delighted that Sylvain is taking on the role of Chairman. I am certain he will play a decisive role in the development and success of Atonco. I am also pleased that Jean-Fran\u00e7ois Chatal will remain engaged in our developments as co-founder and Chief Medical Officer.<\/p>Jean-Pierre Cabocel, Chairman of the Board of Directors<\/cite><\/blockquote>\n\n\n\n

It is an honor to be appointed Chairman of Atonco. With the support of the management team and our talented and experienced advisors, we will optimize our development, strengthen our organization and partnerships to ensure Atonco’s continued growth.<\/p>Sylvain Fanier<\/cite><\/blockquote>\n\n\n\n

About ATONCO<\/h3>\n\n\n\n

ATONCO is a French private company developing molecularly targeted radiopharmaceutical products for oncological applications. Originating from the world-class nuclear medicine centre in Nantes, ATONCO and its partners are committed to the clinical use of alpha-emitting radionuclides, particularly astatine-211 (\u00b2\u00b9\u00b9At).<\/p>\n\n\n\n

For more information, visit www.atonco-pharma.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Atonco today announces that Sylvain Fanier, MSc. EMBA, will succeed Professor Jean-Fran\u00e7ois Chatal as Chairman effective March 16, 2020. Sylvain Fanier has dedicated his career to overseeing and driving the development of several global medical innovations in the healthcare sector. He brings to the company strategic leadership and a global perspective on business and financing, […]<\/p>\n","protected":false},"author":1,"featured_media":1181,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-1180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-atonco-press-releases"],"yoast_head":"\nAtonco Announces Sylvain Fanier as New Chairman of the Company<\/title>\n<meta name=\"description\" content=\"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Atonco Announces Sylvain Fanier as New Chairman of the Company\" \/>\n<meta property=\"og:description\" content=\"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/\" \/>\n<meta property=\"og:site_name\" content=\"Atonco\" \/>\n<meta property=\"article:published_time\" content=\"2020-03-16T10:10:15+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-06T17:31:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin27\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin27\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/\"},\"author\":{\"name\":\"admin27\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"headline\":\"ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO\",\"datePublished\":\"2020-03-16T10:10:15+00:00\",\"dateModified\":\"2026-03-06T17:31:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/sylvain-615.jpg\",\"articleSection\":[\"Atonco press release\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/\",\"name\":\"Atonco Announces Sylvain Fanier as New Chairman of the Company\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/sylvain-615.jpg\",\"datePublished\":\"2020-03-16T10:10:15+00:00\",\"dateModified\":\"2026-03-06T17:31:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\"},\"description\":\"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#primaryimage\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/sylvain-615.jpg\",\"contentUrl\":\"https:\\\/\\\/atonco-pharma.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/sylvain-615.jpg\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/2020\\\/03\\\/16\\\/atonco-announces-appointment-sylvain-fanier-new-chairman\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/\",\"name\":\"Atonco\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/#\\\/schema\\\/person\\\/0abcc6ce783094b44c1902ff2a9283b5\",\"name\":\"admin27\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g\",\"caption\":\"admin27\"},\"sameAs\":[\"https:\\\/\\\/pulsheart-medical.com\"],\"url\":\"https:\\\/\\\/atonco-pharma.com\\\/en\\\/author\\\/admin27\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Atonco Announces Sylvain Fanier as New Chairman of the Company","description":"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/","og_locale":"en_US","og_type":"article","og_title":"Atonco Announces Sylvain Fanier as New Chairman of the Company","og_description":"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.","og_url":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/","og_site_name":"Atonco","article_published_time":"2020-03-16T10:10:15+00:00","article_modified_time":"2026-03-06T17:31:18+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg","type":"image\/jpeg"}],"author":"admin27","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin27","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#article","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/"},"author":{"name":"admin27","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"headline":"ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO","datePublished":"2020-03-16T10:10:15+00:00","dateModified":"2026-03-06T17:31:18+00:00","mainEntityOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/"},"wordCount":316,"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg","articleSection":["Atonco press release"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/","url":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/","name":"Atonco Announces Sylvain Fanier as New Chairman of the Company","isPartOf":{"@id":"https:\/\/atonco-pharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#primaryimage"},"image":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#primaryimage"},"thumbnailUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg","datePublished":"2020-03-16T10:10:15+00:00","dateModified":"2026-03-06T17:31:18+00:00","author":{"@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5"},"description":"Atonco appoints Sylvain Fanier as new Chairman, bringing 30 years of experience in healthcare innovation and medical device companies.","breadcrumb":{"@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#primaryimage","url":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg","contentUrl":"https:\/\/atonco-pharma.com\/wp-content\/uploads\/2020\/03\/sylvain-615.jpg","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/atonco-pharma.com\/en\/2020\/03\/16\/atonco-announces-appointment-sylvain-fanier-new-chairman\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/atonco-pharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATONCO ANNOUNCES THE APPOINTMENT OF SYLVAIN FANIER AS NEW CHAIRMAN OF ATONCO"}]},{"@type":"WebSite","@id":"https:\/\/atonco-pharma.com\/en\/#website","url":"https:\/\/atonco-pharma.com\/en\/","name":"Atonco","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/atonco-pharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/atonco-pharma.com\/en\/#\/schema\/person\/0abcc6ce783094b44c1902ff2a9283b5","name":"admin27","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/94e7a71a0ec4632d35d5add64525ba0c3aee8df62644926cb9b386812d7ccdfb?s=96&d=mm&r=g","caption":"admin27"},"sameAs":["https:\/\/pulsheart-medical.com"],"url":"https:\/\/atonco-pharma.com\/en\/author\/admin27\/"}]}},"_links":{"self":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/comments?post=1180"}],"version-history":[{"count":11,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1180\/revisions"}],"predecessor-version":[{"id":1208,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/posts\/1180\/revisions\/1208"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media\/1181"}],"wp:attachment":[{"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/media?parent=1180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/categories?post=1180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/atonco-pharma.com\/en\/wp-json\/wp\/v2\/tags?post=1180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}